Literature DB >> 25139021

Basis of virulence in a Panton-Valentine leukocidin-negative community-associated methicillin-resistant Staphylococcus aureus strain.

Yan Chen1, Anthony J Yeh2, Gordon Y C Cheung2, Amer E Villaruz2, Vee Y Tan2, Hwang-Soo Joo2, Som S Chatterjee2, Yunsong Yu3, Michael Otto2.   

Abstract

Community-associated (CA) infections with methicillin-resistant Staphylococcus aureus (MRSA) are on a global rise. However, analysis of virulence characteristics has been limited almost exclusively to the US endemic strain USA300. CA-MRSA strains that do not produce Panton-Valentine leukocidin (PVL) have not been investigated on a molecular level. Therefore, we analyzed virulence determinants in a PVL-negative CA-MRSA strain, ST72, from Korea. Genome-wide analysis identified 3 loci that are unique to that strain, but did not affect virulence. In contrast, phenol-soluble modulins (PSMs) and the global virulence regulator Agr strongly affected lysis of neutrophils and erythrocytes, while α-toxin and Agr had a major impact on in vivo virulence. Our findings substantiate the general key roles these factors play in CA-MRSA virulence. However, our analyses also showed noticeable differences to strain USA300, inasmuch as α-toxin emerged as a much more important factor than PSMs in experimental skin infection caused by ST72. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Panton-Valentine leukocidin; alpha-toxin; community-associated infection; methicillin-resistant Staphylococcus aureus; phenol-soluble modulins

Mesh:

Substances:

Year:  2014        PMID: 25139021      PMCID: PMC4296174          DOI: 10.1093/infdis/jiu462

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  45 in total

1.  Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis.

Authors:  Gordon Y C Cheung; Rong Wang; Burhan A Khan; Daniel E Sturdevant; Michael Otto
Journal:  Infect Immun       Date:  2011-03-14       Impact factor: 3.441

2.  A MRSA-terious enemy among us: end of the PVL controversy?

Authors:  Michael Otto
Journal:  Nat Med       Date:  2011-02       Impact factor: 53.440

3.  Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains.

Authors:  Min Li; Gordon Y C Cheung; Jinhui Hu; Decheng Wang; Hwang-Soo Joo; Frank R Deleo; Michael Otto
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

4.  Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes.

Authors:  Grace Soong; Jarin Chun; Dane Parker; Alice Prince
Journal:  J Infect Dis       Date:  2012-03-28       Impact factor: 5.226

5.  Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency.

Authors:  C Tkaczyk; L Hua; R Varkey; Y Shi; L Dettinger; R Woods; A Barnes; R S MacGill; S Wilson; P Chowdhury; C K Stover; B R Sellman
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

6.  Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection.

Authors:  Scott D Kobayashi; Natalia Malachowa; Adeline R Whitney; Kevin R Braughton; Donald J Gardner; Dan Long; Juliane Bubeck Wardenburg; Olaf Schneewind; Michael Otto; Frank R Deleo
Journal:  J Infect Dis       Date:  2011-09-15       Impact factor: 5.226

7.  Direct and synergistic hemolysis caused by Staphylococcus phenol-soluble modulins: implications for diagnosis and pathogenesis.

Authors:  Gordon Y C Cheung; Anthony C Duong; Michael Otto
Journal:  Microbes Infect       Date:  2011-12-07       Impact factor: 2.700

8.  A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice.

Authors:  Ichiro Inoshima; Naoko Inoshima; Georgia A Wilke; Michael E Powers; Karen M Frank; Yang Wang; Juliane Bubeck Wardenburg
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440

9.  Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model.

Authors:  Urszula Lipinska; Katleen Hermans; Lieve Meulemans; Oana Dumitrescu; Cedric Badiou; Luc Duchateau; Freddy Haesebrouck; Jerome Etienne; Gerard Lina
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

Review 10.  Neutrophils in innate host defense against Staphylococcus aureus infections.

Authors:  Kevin M Rigby; Frank R DeLeo
Journal:  Semin Immunopathol       Date:  2011-11-12       Impact factor: 9.623

View more
  14 in total

1.  Characteristics of the community-genotype sequence type 72 methicillin-resistant Staphylococcus aureus isolates that underlie their persistence in hospitals.

Authors:  Eun-Jeong Joo; Ji-Young Choi; Doo Ryeon Chung; Jae-Hoon Song; Kwan Soo Ko
Journal:  J Microbiol       Date:  2016-05-27       Impact factor: 3.422

Review 2.  Virulence Factor Targeting of the Bacterial Pathogen Staphylococcus aureus for Vaccine and Therapeutics.

Authors:  Trevor L Kane; Katelyn E Carothers; Shaun W Lee
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

3.  Dracorhodin Perochlorate attenuates Staphylococcus aureus USA300 virulence by decreasing α-toxin expression.

Authors:  Yumin Liu; Dongxue Shi; Yan Guo; Meng Li; Yonghong Zha; Quankai Wang; Jianfeng Wang
Journal:  World J Microbiol Biotechnol       Date:  2016-11-29       Impact factor: 3.312

4.  The Role of mprF Mutations in Seesaw Effect of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Isolates.

Authors:  Shengnan Jiang; Hemu Zhuang; Feiteng Zhu; Xiang Wei; Junxiong Zhang; Lu Sun; Shujuan Ji; Haiping Wang; Dandan Wu; Feng Zhao; Rushuang Yan; Yunsong Yu; Yan Chen
Journal:  Antimicrob Agents Chemother       Date:  2021-10-18       Impact factor: 5.938

Review 5.  The Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine Antigens.

Authors:  Keenan A Lacey; Joan A Geoghegan; Rachel M McLoughlin
Journal:  Pathogens       Date:  2016-02-17

6.  Phenol-Soluble Modulins Contribute to Early Sepsis Dissemination Not Late Local USA300-Osteomyelitis Severity in Rabbits.

Authors:  Benjamin Davido; Azzam Saleh-Mghir; Frédéric Laurent; Claire Danel; Florence Couzon; Laure Gatin; François Vandenesch; Jean-Philippe Rasigade; Anne-Claude Crémieux
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

7.  Genotypic Diversity of Staphylococcus aureus α-Hemolysin Gene (hla) and Its Association with Clonal Background: Implications for Vaccine Development.

Authors:  Meng Xiao; Rui Zhao; Qi Zhang; Xin Fan; Matthew V N O'Sullivan; Dong-Fang Li; Xin-Ying Wang; Hong-Long Wu; Fanrong Kong; Ying-Chun Xu
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

8.  Surgical Site Infections Caused by Highly Virulent Methicillin-Resistant Staphylococcus aureus Sequence Type 398, China.

Authors:  Lu Sun; Yan Chen; Danying Wang; Haiping Wang; Dandan Wu; Keren Shi; Ping Yan; Yunsong Yu
Journal:  Emerg Infect Dis       Date:  2019-01       Impact factor: 6.883

9.  Virulence determinants associated with the Asian community-associated methicillin-resistant Staphylococcus aureus lineage ST59.

Authors:  Min Li; Yingxin Dai; Yuanjun Zhu; Chih-Lung Fu; Vee Y Tan; Yanan Wang; Xing Wang; Xufen Hong; Qian Liu; Tianming Li; Juanxiu Qin; Xiaowei Ma; Jingyuan Fang; Michael Otto
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

10.  Detection and analysis of methicillin-resistant human-adapted sequence type 398 allows insight into community-associated methicillin-resistant Staphylococcus aureus evolution.

Authors:  Lei He; Hong-Xiang Zheng; Yanan Wang; Katherine Y Le; Qian Liu; Jun Shang; Yingxin Dai; Hongwei Meng; Xing Wang; Tianming Li; Qianqian Gao; Juanxiu Qin; Huiying Lu; Michael Otto; Min Li
Journal:  Genome Med       Date:  2018-01-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.